Search Results - "Hilbert, Anne"
-
1
Adjuvanted H5N1 vaccine induces early CD4⁺ T cell response that predicts long-term persistence of protective antibody levels
Published in Proceedings of the National Academy of Sciences - PNAS (10-03-2009)“…Immune responses to vaccination are tested in clinical trials. This process usually requires years especially when immune memory and persistence are analyzed…”
Get full text
Journal Article -
2
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
Published in Vaccine (24-01-2008)“…Summary Influenza is controlled by protective titres of neutralizing antibodies, induced with the help of CD4 T-cells, and by antiviral T-cell effector…”
Get full text
Journal Article -
3
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults
Published in PloS one (30-09-2011)“…Typhoid fever causes more than 21 million cases of disease and 200,000 deaths yearly worldwide, with more than 90% of the disease burden being reported from…”
Get full text
Journal Article -
4
Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture–Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of Age
Published in The Pediatric infectious disease journal (01-05-2012)“…BACKGROUND:The safety and immunogenicity of the cell-culture–derived seasonal trivalent influenza vaccine ([CCIV]; Optaflu) has been reported previously in…”
Get full text
Journal Article -
5
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines
Published in Science translational medicine (01-06-2011)“…Oil-in-water adjuvants have been shown to improve immune responses against pandemic influenza vaccines as well as reduce the effective vaccine dose, increasing…”
Get more information
Journal Article -
6
Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
Published in The Journal of infectious diseases (15-09-2009)“…BackgroundImmunization remains the best prevention strategy for influenza, but production constraints for egg-based influenza vaccines have prompted the…”
Get full text
Journal Article -
7
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses
Published in Vaccine (09-10-2009)“…Abstract The standard serological methods present limitations for the measurement of immunity against H5N1 influenza strains. The hemagglutination inhibition…”
Get full text
Journal Article -
8
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
Published in Vaccine (08-01-2010)“…Abstract Background Dose-sparing strategies and new production technologies will be necessary to produce adequate supplies of vaccines for pandemic influenza…”
Get full text
Journal Article -
9
Biodegradable microspheres containing influenza A vaccine: immune response in mice
Published in Vaccine (05-03-1999)“…A monovalent influenza split vaccine was microencapsulated in poly( d, l-lactic-co-glycolic acid) (PLGA) and ABA triblock copolymers using a W/O/W double…”
Get full text
Journal Article -
10
Safety and Immunogenicity of a New Fully Liquid DTPw-HepB-Hib Combination Vaccine in Infants
Published in Human vaccines (01-07-2006)“…We assessed the safety and immunogenicity of a fully liquid, DTPw-HepB-Hib combination vaccine (Quinvaxem™) in comparison with separately administered DTPw-Hib…”
Get full text
Journal Article -
11
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
Published in Vaccine (06-07-2012)“…Highlights ► One dose of cell-culture-derived, pandemic influenza vaccine adequate for adults. ► Two doses required for the elderly. Adjuvanted vaccine well…”
Get full text
Journal Article -
12
An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine
Published in Vaccine (12-04-2006)“…To test whether inactivated influenza vaccines distributed during the 2003–2004 influenza season in the northern hemisphere were able to confer protection…”
Get full text
Journal Article -
13
Paediatric tick-borne encephalitis (TBE) vaccines: Schedules to optimise protection
Published in International journal of medical microbiology (01-09-2008)“…Abstract Although tick-borne encephalitis (TBE) vaccines have been used successfully for decades, direct comparisons of different immunisation schedules and…”
Get full text
Journal Article -
14
Safety, Immunogenicity and Dose Ranging of a New Vi-CRM.sub.197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults
Published in PloS one (30-09-2011)“…Background Typhoid fever causes more than 21 million cases of disease and 200,000 deaths yearly worldwide, with more than 90% of the disease burden being…”
Get full text
Journal Article -
15
Immunogenicity and reactogenicity of a combined fully liquid DTPw–HepB–Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine
Published in International journal of infectious diseases (01-01-2011)“…Summary Objectives In this open-label, non-randomized phase II study, the safety and immunogenicity of a fully liquid diphtheria–tetanus–whole cell…”
Get full text
Journal Article -
16
A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador
Published in Revista panamericana de salud pública (01-02-2010)“…To compare the safety and immunogenicity of a booster dose of a fully liquid diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b…”
Get full text
Journal Article -
17
Adjuvanted H5N1 vaccine induces early CD4 super(+) T cell response that predicts long-term persistence of protective antibody levels
Published in Proceedings of the National Academy of Sciences - PNAS (10-03-2009)“…Immune responses to vaccination are tested in clinical trials. This process usually requires years especially when immune memory and persistence are analyzed…”
Get full text
Journal Article -
18
Adjuvanted H5N1 vaccine induces early CD4⺠T cell response that predicts long-term persistence of protective antibody levels
Published in Proceedings of the National Academy of Sciences - PNAS (2009)“…Immune responses to vaccination are tested in clinical trials. This process usually requires years especially when immune memory and persistence are analyzed…”
Get full text
Journal Article -
19
Vacuna liquida combinada DTPw-HepB-Hib como dosis de refuerzo en infantes de El Salvador
Published in Revista panamericana de salud pública (01-02-2010)“…Objetivos. Comparar la seguridad y la inmunogenicidad en infantes saludables de una dosis de refuerzo de una vacuna liquida combinada contra la difteria, el…”
Get full text
Journal Article -
20
Putting it in writing: Offer letter clarifies the employment relationship
Published in Business law today (01-07-2003)Get full text
Magazine Article